Corporate news
Grifols to make a major equity investment in Alkahest Alkahest is a company founded in 2014 by leading scientists who demonstrated at Stanford University (US) that factors in the blood of young animals were able to restore mental capabilities in old animals
+ info
+ info
Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014 Grifols' net revenues rose by 22.4% to 3,355.4 million euros
+ info
+ info
Grifols PhocusRx Certified DIACAP Compliant The PhocusRx system can operate with a low and acceptable level of risk when installed in a Department of Defense facility that meets security requirements.
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
New transfusion medicine solutions
Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info
